Sinco Pharma is the fourth largest marketing, promotion and channel management service provider in the PRC pharmaceutical industry with a market share of 4.2% in terms of revenue for 2016. We are also the only marketing, promotion and channel management service provider for plasma-based pharmaceuticals. The plasma-based pharmaceuticals market in China grew at a CAGR of 25.4% from 2012 to 2016. It is expected to reach RMB98.14 billion in 2021, representing a CAGR of 26.1% from 2017. China’s human albumin market grew rapidly at a CAGR of 22.2%, and is expected to grow at a CAGR of 22.8% from 2017 to 2021.
Your Ideal Partner to Explore the Vast Health Care Market in China
It is used to remedy hypovolemia and hypovolemic shock, abnormally high intracranial pressure, edema and ascites, and to prevent and cure hypoalbuminemia and neonatal hyper-bilirubinemia.
It is used for treating hypophosphatemia and chromic diseases including alcohol intoxication, malnutrition and hypophosphatemic respiratory failure.
Taurolite is used for the treatment of gallstone diseases, or cholelithiasis.
Metastatic prostate cancer, true precocious puberty and Endometriosis